Literature DB >> 7036732

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

T H Hostetter, H G Rennke, B M Brenner.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7036732     DOI： 10.1016/0002-9343(82)90490-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  157 in total

1.  Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy.

Authors:  F Lang; K Klingel; C A Wagner; C Stegen; S Warntges; B Friedrich; M Lanzendorfer; J Melzig; I Moschen; S Steuer; S Waldegger; M Sauter; M Paulmichl; V Gerke; T Risler; G Gamba; G Capasso; R Kandolf; S C Hebert; S G Massry; S Broër
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 2.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

3.  Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.

Authors:  E Hommel; P Andersen; M A Gall; F Nielsen; B Jensen; P Rossing; J Dyerberg; H H Parving
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

4.  Factors related to renal haemodynamics in young type-1 diabetes mellitus patients.

Authors:  B L Johansson; U Berg; U Freyschuss; K Hall; S Troell
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

5.  Angiotensin converting enzyme inhibition reduces proteinuria in Nigerians with chronic renal disease.

Authors:  A A Ajayi; A T Ajayi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Oxidative stress in diabetic nephropathy.

Authors:  N Kashihara; Y Haruna; V K Kondeti; Y S Kanwar
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 7.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 8.  Appropriate drug therapy for improving outcomes in diabetic nephropathy.

Authors:  Robert D Toto
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

9.  Are the 'second generation' oral hypoglycemic agents really different?

Authors:  E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1984 Jan-Mar

10.  Exercise as a provocative test in early renal disease in type 1 (insulin-dependent) diabetes: albuminuric, systemic and renal haemodynamic responses.

Authors:  B Feldt-Rasmussen; L Baker; T Deckert
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.